Featured article: Asthma in the elderly: a double-blind, placebo-controlled study of the effect of montelukast
It is unclear whether leukotriene antagonists benefit older asthmatics. The main purpose of this pilot study is to investigate the effect of adding montelukast to elderly asthmatics’ treatment regimen on asthma symptoms assessed by the Asthma Control Test (ACT) (primary objective), daily symptom scores, number of puffs of albuterol, and spirometric values. Secondary objectives of this study include investigating whether montelukast in elderly asthmatics affects the number of peripheral blood eosinophils and serum IgE levels.
Aims and scope
Asthma Research and Practice is the official publication of Interasma and publishes cutting edge basic, clinical and translational research in addition to hot topic reviews and debate articles relevant to asthma and related disorders (such as rhinitis, COPD overlapping syndrome, sinusitis). The journal has a specialized section which focusses on pediatric asthma research.
Asthma Research and Practice aims to serve as an international platform for the dissemination of research of interest to pulmonologists, allergologists, primary care physicians and family doctors, ENTs and other health care providers interested in asthma, its mechanisms and comorbidities.
Interasma is an international health organization focused on all aspects of asthma that bridge the gap between academia and clinical practice. Since its inception in 1954, Interasma has encouraged asthma education programs through the organization of postgraduate education and the dissemination of the international guidelines on asthma. Interasma is a forum for interdisciplinary discussions where pneumologists, allergologists, pediatricians, and general practitioners, as well as other related health care professionals, have the opportunity to discuss and exchange information between these specialties on asthma research, practice and management.
Professor Fulvio Braido
Dr Braido is the Head of Outpatient Clinics and Day Hospital Service at Allergy and Respiratory Disease Department, University of Genoa. He is also Professor of Respiratory Disease at the School of Medicine, University of Genoa and Professor at the Speciality School of Respiratory Diseases of Genoa. He is a member of the European Academy of Allergy and Clinical Immunology and a reviewer and editorial board member of several reputed journals in the field of allergy and respiratory diseases